TMS denied due to quantity / dose limits by Cigna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for tms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on TMS
## Why Cigna Applies Quantity Limits to TMS
Cigna's quantity-limit denials for TMS typically involve the number of treatment sessions approved — either a cap on the initial course of treatment or a denial of additional sessions beyond a first authorized course. TMS is typically delivered as a defined course of sessions, and Cigna may limit coverage to a standard number of sessions, requiring additional clinical justification to approve an extended or repeat course. This denial is common when a patient needs more sessions than the initial authorization covered, or when a second course of TMS is requested after a period of time.
## Your Appeal Rights
Under ACA §2719 and ERISA §503, you have the right to a full internal appeal followed by independent external review if the internal appeal fails. External review is binding and conducted by an accredited reviewer without any financial connection to Cigna. You typically have approximately 180 days from the denial to file your internal appeal. If the clinical situation is urgent, expedited review is available.
## What to Gather
- Treatment response documentation: Your provider's clinical notes documenting your response (or partial response) to the sessions already completed — this is the most important element for a quantity-limit appeal.
- Treatment plan and rationale: A letter from your TMS provider and prescribing clinician explaining why the requested number of sessions is medically necessary for your specific clinical situation, and what clinical endpoint they are working toward.
- Prior authorization records: Copies of any prior authorizations already granted, confirming the sessions already approved and the basis for that approval.
- Cigna's coverage policy: Obtain the current policy to understand the exact session limit being applied and the criteria under which extended treatment is allowed.
- Professional guideline support: Your clinician can reference guidance from relevant professional societies (such as the applicable psychiatric association guidelines) on treatment course length — without citing specific statistics — as context for the medical-necessity letter.
## Criteria-Mapping Structure
Address the quantity-limit decision directly:
| Cigna Limit Applied | Your Clinical Justification | |---|---| | Session cap cited in denial | [Quote from denial letter] | | Sessions already completed and clinical outcome | [Provider's documented response assessment] | | Why additional sessions are medically necessary | [Prescriber letter with clinical rationale] | | Clinical precedent from Cigna's own policy for extended treatment | [Quote relevant exception criteria from policy] |
Quantity-limit appeals succeed most often when the treating clinician provides a clear, outcome-based rationale explaining what clinical response has been observed and what additional sessions are expected to achieve.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →